Petros Pharmaceuticals, Inc. (PTPI) Gross profit 2020–2024
Petros Pharmaceuticals, Inc. (PTPI) annual gross profit history from SEC filings — each fiscal year as reported.
$3.9MFY2024 · since FY2020: $5.5M → $3.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $3.9M | -7.0% |
| FY2023 | $4.2M | +13.2% |
| FY2022 | $3.7M | -40.4% |
| FY2021 | $6.2M | +12.7% |
| FY2020 | $5.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PTPI financial trends
PTPI RevenuePTPI Net incomePTPI Net marginPTPI Gross marginPTPI Operating incomePTPI Operating marginPTPI Operating cash flowPTPI Free cash flowPTPI Capital expendituresPTPI Return on equityPTPI Stock buybacksPTPI Dividends paidPTPI Total assetsPTPI Total liabilitiesPTPI Shareholders’ equityPTPI overview →